What You May Have Missed in 2024: Part 3

What You May Have Missed in 2024 - Part 2

High-Concentration Cannabinoids: Are They Safe?

What You May Have Missed in 2024: Part 1

Fibrillation - When Ablation is the Way to Go

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide

Diagnosing Primary Aldosteronism

Virtual Urgent Care: Artificial Intelligence Versus Physicians

Pseudogout Syndrome

Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in the Absence of Diabetes

Advanced Practice Clinicians Cannot Replace Primary Care Physicians

Chronic Kidney Disease: What Generalists Need to Know

Health Expenditures of Patients With Diabetes After Bariatric Surgery

Is Adherence to (SEP-1) Linked to Mortality Reduction for Patients with Sepsis?

Metabolic Dysfunction-Associated Steatotic Liver Disease

Lack of Control and Physician Burnout

Teaching Diagnostic Reasoning

Evidence-Based Treatment of Low Back Pain

Diagnostic Reasoning Part 2